Drugs of Abuse Screen - Stimulant Amines - Urine
0090302
 
Ordering Recommendation
Mnemonic
U AMP
Methodology
Enzyme Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Random urine.  
Specimen Preparation
Mix well. Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 1 mL)  
Storage/Transport Temperature
Frozen. Also acceptable: Room temperature or refrigerated.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
 
Stability
Ambient: 1 week; Refrigerated: 5 days; Frozen: 3 years  
Reference Interval
Negative
Interpretive Data
This test detects d-amphetamine, d-methamphetamine, methylenedioxyamphetamine (MDA), and methylenedioxymethamphetamine (MDMA) in human urine. It does not detect l-ephedrine, d-ephedrine, d-pseudoephedrine, l-pseudoephedrine, and phenylpropanolamine. Results greater than or equal to the 1000 ng/mL cutoff are positive. This is a screening test, results are unconfirmed and should be used for medical (treatment) purposes only.
Note
CPT Code(s)
80101
Components
Component Test Code*Component Chart Name
0090302Stimulant Amines Detection
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • Amphetamine, qualitative urine
  • methamphetamine screen
  • Stimulant Amines tox screen
  • Stimulantss urine tox screen
  • Substance abuse screening